A unique small cell lung carcinoma disease progression model shows progressive accumulation of cancer stem cell properties and CD44 as a potential diagnostic marker-Reference-Cited by-同舟云学术

A unique small cell lung carcinoma disease progression model shows progressive accumulation of cancer stem cell properties and CD44 as a potential diagnostic marker

Published:2021-04 Issue: Volume:154 Page:13-22
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Heng Win Sen,Pore Milind,Meijer Coby,Hiltermann T. Jeroen N.^ORCID,Cheah Shiau-Chuen,Gosens Reinoud,Kruyt Frank A.E.^ORCID

Funder

University Medical Centre Groningen

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Small cell lung cancer: will recent progress lead to improved outcomes?;Pietanza;Clin. Cancer Res.,2015

2. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas;Travis;Mod. Pathol.,2012

3. Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes;Zhang;Transl. Lung Cancer Res.,2018

4. Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse models;Shue;Transl. Lung Cancer Res.,2018

5. Current diagnosis and management of small-cell lung cancer;Wang;Mayo Clin. Proc.,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sniping Cancer Stem Cells with Nanomaterials;ACS Nano;2023-11-27

2. The evaluation of tumorigenicity and characterization of colonies in a soft agar colony formation assay using polymerase chain reaction;Scientific Reports;2023-04-03

3. The role of hypoxia-inducible factors in breast cancer stem cell specification;Pathology - Research and Practice;2023-03

4. The role of stem cells in small-cell lung cancer: Evidence from chemoresistance to immunotherapy;Seminars in Cancer Biology;2022-12

5. Targeting cancer stem cell pathways for lung cancer therapy;Current Opinion in Oncology;2022-11-02